Quietly replacing the old way: customers are switching to the company from an entrenched alternative, and the switching
The model's full reasoning — Q1 2023 call → NOWe need answer YES or NO. Need analyze transcript. Question: Does management describe customers currently switching to company from entrenched alternative, and switching still early stages, most potential not converted? Need use only transcript. Transcript: Inogen sells portable oxygen concentrators (POCs). They mention low level of POC-based oxygen therapy penetration in U.S., HME partnerships essential to reaching more patients with Inogen's leading POC and providing HMEs with more competitive business model. "Given the low level of POC-based oxygen therapy penetration in the U.S., HME partnerships are essential to our strategy of reaching more patients with Inogen’s leading POC and providing HMEs with a more competitive business model." This suggests POC-based therapy is replacing something? Need see if management describes switching from entrenched alternative (likely stationary oxygen concentrators or tanks). They say "patients and prescribers having wide access to the most appropriate therapy modality irrespective of point of prescription or how patients might qualify for coverage for POCs." "channel strategy designed to improve ability to serve patients at point of diagnosis and prescription through Inogen and HME partners while refining DTC model to meet needs of patients who desire to switch to POC-based therapy later in disease management journey." "desire to switch to POC-based therapy" - that's switching from something? They mention "low level of POC-based oxygen therapy penetration in the U.S." implies most patients still using other modalities (stationary concentrators, tanks). So substitution is underway? They say "we continue to see underlying demand" and "low penetration" means early stages. But do they describe customers actually switching now? They mention rental revenue growth, prescriber channel, referrals. They mention "patients who desire to switch to POC-based therapy later" - that's a desire, not necessarily current. But also "HME partnerships essential to our strategy of reaching more patients with Inogen’s leading POC and providing HMEs with a more competitive business model." HMEs are adopting Inogen POCs to replace? Need see if management explicitly says customers are switching from incumbent alternative.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| IFS | Intercorp Financial Services Inc. | Q1 2024 | 2024-05-14 | C+ |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| BIG | Big Lots, Inc. | Q1 2022 | 2022-05-27 | F |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| INST | Instructure's | Q4 2017 | 2018-02-12 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| BLKB | Blackbaud, Inc. | Q1 2017 | 2017-05-02 | B+ |
| EVBN | Evans Bancorp, Inc. | Q4 2016 | 2017-02-06 | B+ |
| BDC | Belden Inc. | Q4 2016 | 2017-02-02 | B |
BLKB · Q1 2017 → YESThe question is: Does management describe that customers are currently SWITCHING TO THE COMPANY FROM AN ENTRENCHED ALTERNATIVE THEY PREVIOUSLY RELIED ON, and that this switching is still in its early ...YES Management describes customers switching from entrenched alternatives (legacy hardware systems, older Raiser's Edge versions, standalone point solutions) to Blackbaud's cloud solutions like NXT, with examples of recent replacements and migrations already occurring. They also note that much of the potential remains, as the installed base of legacy methods is still large 25% of subscription revenue, and they describe the opportunity as "really early days" with substantial distance left to run. This fits the criteria of a present-tense substitution pattern in the market, not just future hope. The high retention on their own base (93%) combined with declining maintenance revenue shows the shift is active and ongoing, while new wins against competitors and legacy alternatives are happening now. The TAM of $7 billion with hundreds of thousands of addressable customers reinforces that switching is early-stage relative to the total opportunity. The answer is YES. The question is answered with YES. The question is answered with YES.
BLZE · Q3 2022 → YESThe question is: Does management describe that customers are currently SWITCHING TO THE COMPANY FROM AN ENTRENCHED ALTERNATIVE THEY PREVIOUSLY RELIED ON, and that this switching is still in its early ...YES The transcript shows management describing current customer switches from entrenched alternatives (AWS for urlscan.io; Synology NAS/on-prem for Fiture; broader AWS and on-prem users), with these as real, ongoing patterns. They explicitly note that much of the potential remains ("so much of the world's data is still on-premises" and "customers that are inside of AWS and others"), confirming the substitution is early-stage relative to the large installed base. This is conveyed directly in Gleb's responses as a present-tense reality, not merely anticipated. The two examples plus the broader opportunity framing establish a coherent substitution underway, with the company being substituted in. The investor question on percentages and Gleb's reply reinforce the pattern without contradicting the current movement. No single-event or future-only framing applies here. Thus, both conditions are met.
APPS · Q1 2024 → YESThe question is: Does management describe that customers are currently SWITCHING TO THE COMPANY FROM AN ENTRENCHED ALTERNATIVE THEY PREVIOUSLY RELIED ON, and that this switching is still in its early ...YES The transcript shows management describing customers shifting from Apple/Google app stores to DT Hub and SingleTap-enabled alternative distribution as an ongoing, early-stage substitution. Bill Stone notes the company has already launched DT Hub with four U.S. operators and is generating revenue today, while highlighting "increasing pressure on the duopoly" and 5 monetization ways for SingleTap that enable publishers to direct-download apps outside traditional stores. He explicitly calls it "very early days and not yet material to our overall results" and "early innings," confirming the installed base of the old way remains large and the switch is just beginning with incremental RPD gains from devices engaging the new platform. This meets the criteria of a present-tense substitution underway, with the company positioned as the alternative being adopted.